Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Overview of attention for article published in Genome Medicine, August 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 27,014 followers.

"Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy" https://t.co/r0YGwgpSuu

RT @KnappskogStian: Very happy to say that our paper on clonal evolution during neoadjuvant chemo, by @andvenizelos and the team, is out to…

RT @andvenizelos: 🎉Today’s news in @GenomeMedicine. What an amazing feeling to see this piece of work published! “Clonal evolution in local…

RT @KnappskogStian: Very happy to say that our paper on clonal evolution during neoadjuvant chemo, by @andvenizelos and the team, is out to…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.